
    
      Single-Blind, Randomised, Placebo-Controlled First Time in Human Study to Evaluate Safety,
      Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Escalating Doses of
      GSK1018921 in Healthy Volunteers and to assess the effect of a single dose of GSK1018921 on
      quantitative EEG and Mismatch Negativity in a separate cohort of healthy smoker volunteers
    
  